Company intelligence / Profile preview

Spesana

Memphis, Tennessee, United States

Ownership: Private
Development stage: Other

Overview

Spesana’s platform is commercially deployed and used to support patient navigation, clinical trial collaboration, prior authorization, and molecular diagnostic workflows across over 140 clinical sites; reported to deliver a 60% improvement in appropriate precision medicine diagnostic use for client organizations

Therapeutic areas: Oncology
Modalities: Device (healthcare platform)Digital Health SolutionSoftware Platform
Industry: Digital Health Medical Devices

Partnerships

FamGenix (hereditary risk screening integration)Protean BioDiagnostics (real-time diagnostic collaboration)

Beyond the preview

Go deeper on Spesana.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spesana.

Explore the full profile